1. Home
  2. DCTH vs DXYZ Comparison

DCTH vs DXYZ Comparison

Compare DCTH & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • DXYZ
  • Stock Information
  • Founded
  • DCTH 1988
  • DXYZ N/A
  • Country
  • DCTH United States
  • DXYZ
  • Employees
  • DCTH N/A
  • DXYZ N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • DXYZ
  • Sector
  • DCTH Health Care
  • DXYZ
  • Exchange
  • DCTH Nasdaq
  • DXYZ Nasdaq
  • Market Cap
  • DCTH 630.4M
  • DXYZ 413.3M
  • IPO Year
  • DCTH N/A
  • DXYZ 2024
  • Fundamental
  • Price
  • DCTH $13.57
  • DXYZ $38.91
  • Analyst Decision
  • DCTH Strong Buy
  • DXYZ
  • Analyst Count
  • DCTH 4
  • DXYZ 0
  • Target Price
  • DCTH $24.00
  • DXYZ N/A
  • AVG Volume (30 Days)
  • DCTH 734.6K
  • DXYZ N/A
  • Earning Date
  • DCTH 08-04-2025
  • DXYZ N/A
  • Dividend Yield
  • DCTH N/A
  • DXYZ N/A
  • EPS Growth
  • DCTH N/A
  • DXYZ N/A
  • EPS
  • DCTH N/A
  • DXYZ N/A
  • Revenue
  • DCTH $53,850,000.00
  • DXYZ N/A
  • Revenue This Year
  • DCTH $155.42
  • DXYZ N/A
  • Revenue Next Year
  • DCTH $37.93
  • DXYZ N/A
  • P/E Ratio
  • DCTH N/A
  • DXYZ N/A
  • Revenue Growth
  • DCTH 1068.87
  • DXYZ N/A
  • 52 Week Low
  • DCTH $7.17
  • DXYZ N/A
  • 52 Week High
  • DCTH $18.23
  • DXYZ N/A
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 38.26
  • DXYZ N/A
  • Support Level
  • DCTH $12.98
  • DXYZ N/A
  • Resistance Level
  • DCTH $14.18
  • DXYZ N/A
  • Average True Range (ATR)
  • DCTH 0.68
  • DXYZ 0.00
  • MACD
  • DCTH -0.28
  • DXYZ 0.00
  • Stochastic Oscillator
  • DCTH 15.95
  • DXYZ 0.00

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About DXYZ Destiny Tech100 Inc. Common Stock

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

Share on Social Networks: